What is LOPJLB’s current signal on HRTX?

LOPJLB’s latest quantitative signal on Heron Therapeutics, Inc. (HRTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is HRTX in?

Heron Therapeutics, Inc. (HRTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Heron Therapeutics, Inc. (HRTX) do?

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from d…

Where is Heron Therapeutics, Inc. based / listed?

Heron Therapeutics, Inc. is based in US, listed on NASDAQ.

Heron Therapeutics, Inc. (HRTX) Stock · SELL · CRISIS

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $51M
Avg volume: 3.2M
Beta: 1.67
P/E (TTM): -1.72

Short % float: 32.73%
Days to cover: 24.4
SI change: +1.4%

1W: +0.00%
1M: -30.43%
3M: -62.79%
YTD: -74.60%

vs SPY 1W: +1.19%
vs SPY 1M: -33.76%
vs SPY 3M: -65.18%
vs SPY YTD: -86.36%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Sector peers

Industry peers

Prediction markets

Company news